Open AccessPrognostic value of [18F]FDG PET/CT in patients with CNS lymphoma receiving ibrutinib-based therapies
Author(s) -
Simone Krebs,
Audrey Mauguen,
Onur Yıldırım,
Vaios Hatzoglou,
Jasmine H. Francis,
Lauren Schaff,
Ingo K. Mellinghoff,
Heiko Schöder,
Christian Grommes
Publication year - 2021
Publication title -
european journal of nuclear medicine and molecular imaging
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.313
H-Index - 163
eISSN - 1619-7089
pISSN - 1619-7070
DOI - 10.1007/s00259-021-05386-0
Subject(s) - ibrutinib , medicine , hazard ratio , positron emission tomography , standardized uptake value , lymphoma , pet ct , nuclear medicine , oncology , radiology , confidence interval , leukemia , chronic lymphocytic leukemia
Current clinical and imaging tools remain suboptimal for predicting treatment response and prognosis in CNS lymphomas. We investigated the prognostic value of baseline [ 18 F]FDG PET in patients with CNS lymphoma receiving ibrutinib-based treatments.